Needham Maintains Buy on Globus Medical, Raises Price Target to $114
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $112 to $114.
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $112 to $114.